News & Events :: CNS Pharmaceuticals, Inc. (CNSP)

Recent News View All News

CNS Pharmaceuticals Receives Approval from U.S. FDA for Protocol Amendment to Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM

Jun 23, 2022 8:35am EDT

CNS Pharmaceuticals Announces Presentation of Ongoing Potentially Pivotal Berubicin Clinical Trial Design at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting

Jun 8, 2022 8:35am EDT

Upcoming Events View IR Calendar

Annual Meeting of Stockholders

Jul 27, 2022 • 9:00 am EDT

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings